CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us
  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Drug Discovery and Development Companies Ai Drug Discovery Company of The Year - 2024

Life Sciences Review

Drug Discovery and Development

Braving the Situation of Medical Scheduling

Braving the Situation of Medical Scheduling

Melissa Harder

Director of Scheduling

Community Health Systems

Ipsc Human Cell Platforms

The Discovery Engine Behind Next-Generation Human Cell Models

David Llewellyn

President & CEO

Trailhead Biosystems

Featured Issue
PreviousNext

Featured Categories

iPSC Human Cell Platforms

Research Peptides Manufacturing Companies

#

Microbiological Considerations for Achieving Drug Manufacturing Excellence

Jessica Wilson Rayse, Assoc Director of Product Management, Accugenix Charles River Laboratories [NYSE: CRL]
#

Sound Healing with Tuning Fork use in Rehabilitation

Jessica Ochis, OTR/L, CHT, Director of Occupational Therapy Community Memorial Hospital
#

Research Peptides Manufacturing Companies

Quality Transparency as a Foundation in Research Peptides

Jay Campbell, Co-Founder and Visionary BioLongevity Labs
#

Clinical Trial And Drug Development Services

Fixing What Slows Medicine Down

Frederick O. Cope, PhD, MS(2), FACN, CEO Physis International
Accelerating Early-Stage Drug Development

Accelerating Early-Stage Drug Development

Safwan Kezbor, M.D., Executive Medical Director, Global Clinical Development

Shionogi Inc

Collaborative Drug Discovery (CDD): Transforming Data Management in Drug Discovery

Transforming Data Management in Drug Discovery

Dr. Barry A. Bunin, CEO and President

Collaborative Drug Discovery (CDD)

#

Balancing Complex API Manufacturing with Long-Term Supply Reliability

Marcella van Dinther, Commercial Project Manager

Aspen API

News

Boosting Laboratory Accuracy: How Proficiency Testing Shapes the Future of Life Sciences

Clinical Laboratories Become a Strategic Driver of Modern Healthcare

Hospital-Based Stem Cell Programs Highlight the Access Challenge

Elevating Patient Care: The Impact of AI on Prognostic Testing

Loading...
#

A Specialist in Right Sizing Life Science Technologies

Kevin F. Shea, Principal, Driftpin Consulting

#

Driving Excellence in Clinical and Regulatory Recruitment

Mara Vaughn, Co-Founder & President, TriNet Pharma

#

The Protein Specialist

Joshua Carter, Co-founder & CEO, Helix BioStructures

#

Creating the Path of AI-Powered Drug Discovery

Andy Nappin, CEO , Janusz Sowadski, Founder, DNA SEQ

Embrace the Future with August eTech IT Solutions

Embrace the Future with August eTech IT Solutions

Janice A. Mahlmann, CEO

Enhancing Healthcare Outcomes with Tailored Solutions

Enhancing Healthcare Outcomes with Tailored Solutions

Heather Rose, CEO, P3 Technology

#

Boutique Marketing Communications Agency

Mastering the Art of Life Sciences Storytelling

Shannon Meirzon,, Co-Founder, Pyxis Communications

News

Medicine Development Built around Supply Confidence

AI and High-Content Analytics Increase the Value of iPSC Cell Data.

iPSC Human Cell Platforms Move Drug Discovery Closer to Human Biology

Cell Therapy Progress Turns iPSC Platforms into Manufacturing Infrastructure.
Breaking The Drug Resistance Barrier

Cancer Drug Resistance

Breaking The Drug Resistance Barrier

Anita Davidson, DPT, Founder And CEO, Creative Biotherapeutics (CBT) LLC

Transdermal, Transformed

Novel Transdermal Drug Delivery System

Transdermal, Transformed

Hirotoshi Adachi, Ph.D., COO, PassPort Technologies

Where Science Meets Compassion

Rare Dermatologic Disorders Medication Development

Where Science Meets Compassion

Karen McGuire, CEO and Co-Founder, BioMendics

Accelerating Innovation in Inflammation and Immunology

Drug Development Consulting

Accelerating Innovation in Inflammation and Immunology

Michael D. Howell, PhD, Founder and President, Mountaineer Biosciences

#

Drug Development Solutions

Unifying the Drug and Diagnostic Lifecycle Through One Platform

Mark Thornton, CEO, VION Biosciences

#

Integrated Drug Discovery Platform

Next-Generation Therapies for Historically Untreatable Conditions

Ameet Nathwani, CEO, Isaac Klein, CSO, Dewpoint Therapeutics

#

BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES-02 Trial Advances and JPM Week Approaches

Karen McGuire, PhD, CEO and Founder

#

Danaher: Building Scalable Infrastructure for Modern Biomanufacturing
Advancing Broad-Spectrum Therapies for Infectious Disease

Infectious Diseases Novel Therapies Development

Advancing Broad-Spectrum Therapies for Infectious Disease

Ajay Gupta, CEO, President and Chairman, Celestial Therapeutics

Alphinity USA: Transforming Bioprocessing with PIXER<sup>®</sup>

Alphinity USA: Transforming Bioprocessing with PIXER®

Craig Vincze, Vice President & Co-Founder, Alphinity

#

A Lifetime Dedicated to Drug Development and Patient Care

Frederick O. Cope, CEO

News

Human Cell Models for Drug Discovery's Next Testing Standard

Research Peptides Manufacturing Company of the Year

Selecting Microbiology Testing Services for Regulated Product Release

Preclinical Research Services for a More Demanding Drug Pipeline
Why Verification Is the New Standard in Research Peptide Manufacturing

Why Verification Is the New Standard in Research Peptide Manufacturing

Josh Felber, Co-Founder

Compassionate Care Enhanced by Digital Innovation

Compassionate Care Enhanced by Digital Innovation

Simon Curtis, M.H.A., Chief Ambulatory Officer & Chief Operating Officer, Physician Practices, Duke University Health System

Managing Changes for Improved Outcomes

Managing Changes for Improved Outcomes

Mike VanDerwerken, Director of Pharmacy, Saratoga Hospital

Optimizing Healthcare Procurement and Supply Chain Management

Optimizing Healthcare Procurement and Supply Chain Management

Cesar A. Roman, Director of Strategic Sourcing and Procurement Operations, University Health

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://drug-discovery-and-development.lifesciencesreviewapac.com